down arrow

Windlas Biotech

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE0H5O01029
  • NSEID: WINDLAS
  • BSEID: 543329
INR
960.45
63.55 (7.09%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 51.24 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

924.40970.00

52 Week

494.701,197.00
Valuation
Technical
Day's Volume

CASH

51.24 k (-10.13%) Volume

Shareholding (Dec 2024)

FII

1.55%

Held by 26 FIIs

DII

10.26%

Held by 7 DIIs

Promoter

62.51%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Stock is technically in a Mildly Bearish range

  • The technical trend has deteriorated from Mildly Bullish on 08-Apr-25 and has generated 4.29% returns since then
  • The stocks Bollinger Band and KST technical factors are also Bearish
stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 2,007 Cr (Small Cap)

stock-summary
P/E

30.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.41

stock-summary
Return on Equity

12.99%

stock-summary
Price to Book

3.98

Revenue and Profits (1 Year):
Net Sales:
195 Cr
(Quarterly Results - Dec 2024)
Net Profit:
16 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
1.76%
0%
1.76%
1 Year
75.62%
0%
75.62%
2 Years
283.34%
1.52%
284.86%
3 Years
298.53%
3.48%
302.01%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Latest dividend: 4 per share ex-dividend date: Sep-05-2023

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
17.36%
EBIT Growth (5y)
22.01%
EBIT to Interest (avg)
37.53
Debt to EBITDA (avg)
0.16
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.35
Tax Ratio
24.35%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
11.81%
ROCE (avg)
21.64%
ROE (avg)
11.76%
Valuation key factors
Factor
Value
P/E Ratio
30
Industry P/E
33
Price to Book Value
3.98
EV to EBIT
24.94
EV to EBITDA
18.55
EV to Capital Employed
6.06
EV to Sales
2.31
PEG Ratio
1.82
Dividend Yield
NA
ROCE (Latest)
24.04%
ROE (Latest)
12.99%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 4 Schemes (7.11%)

FIIs

Held by 26 FIIs (1.55%)

Promoter with highest holding

Akw Wbl Family Private Trust (through Its Trustees Ashok Vimla Trusteeship Services Private Limited) (40.1%)

Highest Public shareholder

Icici Prudential Pharma Healthcare And Diaganostics (p.h.d) Fund (6.28%)

Individual Investors Holdings

21.54%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 4.29% vs 6.77% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -0.51% vs 16.17% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "195.02",
          "val2": "187.00",
          "chgp": "4.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "24.63",
          "val2": "23.05",
          "chgp": "6.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.46",
          "val2": "1.10",
          "chgp": "32.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "15.58",
          "val2": "15.66",
          "chgp": "-0.51%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "12.63%",
          "val2": "12.33%",
          "chgp": "0.30%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 21.75% vs 17.73% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 11.65% vs 18.69% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "362.15",
          "val2": "297.46",
          "chgp": "21.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "43.92",
          "val2": "35.83",
          "chgp": "22.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.60",
          "val2": "0.52",
          "chgp": "207.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "29.14",
          "val2": "26.10",
          "chgp": "11.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "12.13%",
          "val2": "12.05%",
          "chgp": "0.08%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 21.21% vs 23.44% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 8.54% vs 32.14% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "557.17",
          "val2": "459.67",
          "chgp": "21.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "68.55",
          "val2": "56.16",
          "chgp": "22.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.06",
          "val2": "0.83",
          "chgp": "268.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "44.72",
          "val2": "41.20",
          "chgp": "8.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "12.30%",
          "val2": "12.22%",
          "chgp": "0.08%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 22.97% vs 10.12% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 36.50% vs 11.92% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "630.96",
          "val2": "513.08",
          "chgp": "22.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "78.17",
          "val2": "60.22",
          "chgp": "29.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.11",
          "val2": "0.79",
          "chgp": "40.51%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "58.19",
          "val2": "42.63",
          "chgp": "36.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "12.39%",
          "val2": "11.74%",
          "chgp": "0.65%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
195.02
187.00
4.29%
Operating Profit (PBDIT) excl Other Income
24.63
23.05
6.85%
Interest
1.46
1.10
32.73%
Exceptional Items
0.00
0.00
Consolidate Net Profit
15.58
15.66
-0.51%
Operating Profit Margin (Excl OI)
12.63%
12.33%
0.30%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 4.29% vs 6.77% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is -0.51% vs 16.17% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
362.15
297.46
21.75%
Operating Profit (PBDIT) excl Other Income
43.92
35.83
22.58%
Interest
1.60
0.52
207.69%
Exceptional Items
0.00
0.00
Consolidate Net Profit
29.14
26.10
11.65%
Operating Profit Margin (Excl OI)
12.13%
12.05%
0.08%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 21.75% vs 17.73% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 11.65% vs 18.69% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
557.17
459.67
21.21%
Operating Profit (PBDIT) excl Other Income
68.55
56.16
22.06%
Interest
3.06
0.83
268.67%
Exceptional Items
0.00
0.00
Consolidate Net Profit
44.72
41.20
8.54%
Operating Profit Margin (Excl OI)
12.30%
12.22%
0.08%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 21.21% vs 23.44% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 8.54% vs 32.14% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
630.96
513.08
22.97%
Operating Profit (PBDIT) excl Other Income
78.17
60.22
29.81%
Interest
1.11
0.79
40.51%
Exceptional Items
0.00
0.00
Consolidate Net Profit
58.19
42.63
36.50%
Operating Profit Margin (Excl OI)
12.39%
11.74%
0.65%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 22.97% vs 10.12% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 36.50% vs 11.92% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Windlas Biotech Ltd stock-summary
stock-summary
Windlas Biotech Ltd
Small Cap
Pharmaceuticals & Drugs
Windlas Biotech Limited (formerly known as Windlas Biotech Private Limited) was incorporated in 2001. The Company converted from a Private Limited Company to a Public Limited Company and the name of the Company was changed to `Windlas Biotech Limited'. A fresh Certificate of Incorporation dated April 15, 2021, granted by the Registrar of Companies, Uttarakhand at Dehradun. The Company is engaged in manufacturing and trading of pharmaceutical products.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."